financetom
Business
financetom
/
Business
/
Website Creator Wix Gains After Q1 Print, What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Website Creator Wix Gains After Q1 Print, What's Going On?
May 20, 2024 6:20 AM

Wix.com Ltd ( WIX ) reported its fiscal first-quarter 2024 results. Revenue grew 12% Y/Y to $419.8 million, beating the analyst consensus estimate of $417.8 million. 

Adjusted EPS of $1.29 beat the analyst consensus estimate of $1.03. The stock gained after the results.

Partners revenue in the first quarter of 2024 was $138.4 million, up 33% y/y.

Segments: Creative Subscription revenue increased 9% Y/Y to $304.3 million. The Creative Subscriptions bookings climbed 7% Y/Y to $334.6 millionCreative Subscriptions ARR was $1.24 billion, up 10% Y/Y.

Business Solutions’ revenue rose 20% Y/Y to $115.5 million, and the bookings jumped 21% Y/Y to $122.6 million. 

The adjusted gross margin expanded to 68% from 67% a year ago. Wix.com ( WIX ) generated $113.8 million in operating cash flow and held $883.5 million in cash and cash equivalents as of March-end.

Avishai Abrahami, Wix Co-founder and CEO said, “This outperformance was underpinned by robust business fundamentals as well as strong product traction, particularly for our expansive AI product offering and Wix Studio. Notably, we saw extremely strong usage of our AI Website Builder that was launched earlier in the quarter with hundreds of thousands of sites already created using the tool over just a few months. Wix Studio also continues to perform ahead of plan, with over one million Studio accounts created since our August launch.”

Outlook: Wix.com ( WIX ) expects fiscal second-quarter revenue of $431 million – $435 million versus the consensus of $435.21 million.

Wix.com ( WIX ) expects fiscal 2024 revenue of $1.738 billion – $1.761 billion (prior $1.726 billion-$1.757 billion) vs. the consensus of $1.75 billion. Wix.com ( WIX ) projects 2024 bookings of $1.796 billion – $1.826 billion (prior $1.784 billion – $1.813 billion).

The company expects to generate free cash flow, excluding headquarters costs, of $445 million – $455 million (prior $370 million – $400 million.

Price Action: WIX shares are up 9.82% at $149.00 premarket at the last check Monday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pfizer's RSV Vaccine Meets Primary Endpoints in Study of Participants Under 60 Years; Seeks Expanded Access
Pfizer's RSV Vaccine Meets Primary Endpoints in Study of Participants Under 60 Years; Seeks Expanded Access
Apr 9, 2024
08:49 AM EDT, 04/09/2024 (MT Newswires) -- Pfizer ( PFE ) said key data from an ongoing phase 3 clinical trial of its Abrysvo vaccine, which the pharmaceutical giant is developing for the treatment of respiratory syncytial virus, or RSV, met endpoints and it's going to seek wider access for the shot. The study evaluating a single dose of the...
Sector Update: Consumer
Sector Update: Consumer
Apr 9, 2024
08:48 AM EDT, 04/09/2024 (MT Newswires) -- Consumer stocks were edging higher premarket Tuesday, with the Consumer Staples Select Sector SPDR Fund (XLP) and Consumer Discretionary Select Sector SPDR Fund (XLY) each slightly higher recently. Norwegian Cruise Line Holdings ( NCLH ) was 0.2% higher after it disclosed a new order for eight ships to be built by Italy's Fincantieri,...
Alkermes Says Potential Narcolepsy Drug Improves Wakefulness in Phase 1b Study
Alkermes Says Potential Narcolepsy Drug Improves Wakefulness in Phase 1b Study
Apr 9, 2024
08:49 AM EDT, 04/09/2024 (MT Newswires) -- Alkermes ( ALKS ) said Tuesday that its phase 1b study of ALKS 2680, a once-daily potential treatment for narcolepsy, showed enhanced wakefulness in patients with narcolepsy type 2 and idiopathic hypersomnia. ALKS 2680 showed clinically meaningful and statistically significant improvements in mean sleep latency compared with placebo across all doses tested in...
Oil Prices Steady Early Tuesday as Geopolitical Concerns Ease Amid Tight Supply
Oil Prices Steady Early Tuesday as Geopolitical Concerns Ease Amid Tight Supply
Apr 9, 2024
08:45 AM EDT, 04/09/2024 (MT Newswires) -- Oil prices were mostly steady early on Tuesday following two losing sessions as supply remains tight even as Middle East tensions ease slightly. West Texas Intermediate crude for May delivery was last seen down US$0.16 to US$86.27 per barrel. while June Brent crude, the global benchmark, was up US$0.02 to US$90.40. The geopolitical...
Copyright 2023-2026 - www.financetom.com All Rights Reserved